Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
TWST | NASDAQ | USD | Real-time | |
0ME | TradeGate | EUR | Delayed | |
0ME | Frankfurt | EUR | Delayed |
Twist Bioscience Corporation reported earnings results for the second quarter and six months ended March 31, 2024. For the second quarter, the company reported sales was USD 75.3 million compared to USD 60.18 million a year ago. Net loss was USD 45.49 million compared to USD 59.16 million a year ago. Basic loss per share from continuing operations was USD 0.79 compared to USD 1.04 a year ago. Diluted loss per share from continuing operations was USD 0.79 compared to USD 1.04 a year ago.For the six months, sales was USD 146.8 million compared to USD 114.42 million a year ago. Net loss was USD 88.5 million compared to USD 100.98 million a year ago. Basic loss per share from continuing operations was USD 1.54 compared to USD 1.78 a year ago. Diluted loss per share from continuing operations was USD 1.54 compared to USD 1.78 a year ago.
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Revenue | 75.3 | 71.5 | 66.95 | 63.74 |
Gross Profit | 30.88 | 28.96 | 24.52 | 21.9 |
Operating Income | -48.89 | -46.98 | -50.08 | -48.69 |
Net Income | -45.49 | -43.01 | -46.24 | -57.4 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Assets | 702.85 | 732.82 | 776.4 | 810.33 |
Total Liabilities | 142.72 | 142.77 | 152.97 | 152.78 |
Total Equity | 560.13 | 590.04 | 623.43 | 657.55 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -19.42 | -22.97 | -20.7 | -23.41 |
Cash From Investing Activities | -5.24 | 4.16 | -2.25 | 18.67 |
Cash From Financing Activities | 1.83 | -1.47 | 0.442 | -0.661 |
Net Change in Cash | -22.9 | -20.16 | -22.56 | -5.72 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review